Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Insulin Resistance 1 Hyperphagia 1 Hyperglycemia 1

Interventions

Insulin Glargine 4 Insulin 3 Alpelisib 3 volagidemab 2 Metformin 2 Fulvestrant 2 ziprasidone 1 relacorilant 1 pembrolizumab 1 olaparib 1 exemestane 1 dapagliflozin 1 Vildagliptin 1 Tamoxifen 1 Standard of Care 1 Olanzapine 1 Letrozole 1 Insulin Lispro 1 Insulin Aspart 1 Injections 1 Electrocardiography 1 DNA, Ribosomal 1 Control Groups 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperglycemia × DNA, Ribosomal × Clear all

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡